Business Wire

Wolters Kluwer Celebrates the 25th Anniversary of UpToDate with Launch of 25th Specialty, Anesthesiology

Del

Wolters Kluwer Health announced today that UpToDate ®, the acclaimed evidence-based clinical decision support (CDS) resource, is commemorating its 25 th anniversary with the launch of its 25 th clinical specialty, anesthesiology.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171005005691/en/

In 1992, Dr. Burton “Bud” Rose, a renowned nephrologist and medical textbook author, created UpToDate in the basement of his house. Initially a nephrology-focused disease reference tool accessed via floppy disk, UpToDate has since grown to become one of the most trusted and indispensable clinical resources used by clinicians around the world to diagnose and treat patients.

Denise Basow, MD, President and CEO of Clinical Effectiveness at Wolters Kluwer, said, “Dr. Bud Rose’s real genius was to say, ‘Instead of writing about a particular disease, let’s write about the specific clinical questions that a clinician has, apply the best evidence to answer those questions, and then make very specific recommendations for care.’” She adds, “Today with UpToDate, we are changing more than 300,000 medical decisions every day in more than 180 countries.”

Over the past 25 years, UpToDate has grown as a vital clinical resource to include more than 10,500 clinical topics in 25 specialties. A clinical faculty of more than 6,500 physician authors, editors, and peer-reviewers from 53 countries apply their deep clinical domain expertise to critically evaluate available medical literature and produce original content in a succinct, searchable format that can be quickly and easily accessed at the point of care. Today, more than 1.3 million clinicians in 187 countries consult UpToDate via the website and mobile app, viewing more than 32 million topics per month.

Watch our special UpToDate 25th-anniversary video: https://youtu.be/23GYp2uWaUg

The Latest Evidence to Support the Anesthesiology Specialty
In concert with its 25th anniversary, UpToDate introduces its 25th specialty, anesthesiology. This new specialty covers anesthesia topics related to surgical procedures and other interventions, pain management, opioid avoidance, blood transfusion, and postoperative critical care. Led by Editors-in-Chief, Roberta Hines, MD; Stephanie B. Jones, MD; and Lena S. Sun, MD, the topics in the specialty are written to assist anesthesiologists and nurse anesthetists with finding the best evidence to manage perioperative care for complex patients undergoing common and uncommon procedures, including preoperative consultation, intraoperative anesthetic management, postoperative acute care, and optimal pain management. The new specialty is also a vital resource for general practice clinicians as well as specialists such as surgeons who routinely care for patients together with anesthesiologists.

The specialty’s actionable, evidence-based content is authored, edited and reviewed by 190 world-renowned anesthesiology experts. With 271 topics associated with anesthesiology, UpToDate provides comprehensive coverage complemented by 897 graphics and 96 recommendations that are graded to specify the strength of the recommendations and the quality of their underlying evidence. Additionally, 19 patient education topics provide clinical guidance that can be shared with patients. The specialty’s content will continue to expand in the coming years.

“The practice of anesthesia continues to grow more complex and challenging, as patients with significant medical comorbidities increasingly undergo complicated surgical procedures. As we commemorate a quarter-century of helping clinicians make the best care decisions, we’re committed to supporting anesthesiologists and clinicians in other specialties alike with comprehensive, trustworthy guidance from experts in the field,” said Dr. Basow.

About Wolters Kluwer
Wolters Kluwer N.V. (AEX: WKL) is a global leader in information services and solutions for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.

Wolters Kluwer reported 2016 annual revenues of €4.3 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries and employs 19,000 people worldwide.

Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and the organization, visit http://www.wolterskluwer.com/, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.

For more information about Wolters Kluwer’s solutions and organization, visit www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.

Contact information

Wolters Kluwer | Clinical Effectiveness
André Rebelo, +1 781-392-2411
Public & Analyst Relations Manager, UpToDate
andre.rebelo@wolterskluwer.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Acuris Risk Intelligence Celebrates 350 Direct Customers and Wins Compliance Awards11.12.2018 11:00Pressemelding

Acuris Risk Intelligence, a trusted and independent provider of data intelligence for Anti-Money Laundering, Third Party Risk and Cyber Security professionals, today announces that it now serves 350 direct customers worldwide, helping them to mitigate risk and effectively comply with regulations. This significant milestone nearly doubles its direct client base compared to this time last year and is only two months since the relaunch of the brand, formerly known as C6. Whilst the business has been successful since its inception in 2004 in selling its data via major channel partners, this is a noteworthy milestone as it reflects the success of focusing on direct customer outreach. The business continues to work with some of the biggest compliance platforms in the world as an integrated provider. Acuris Risk Intelligence has also won FinTech/RegTech Rising Star and Best Financial Crime Intelligence Data at The Compliance Register Platinum Awards 2018 as well as executing a successful expa

Wound Care: Nexodyn® AOS Comes to Fruition in Slovakia11.12.2018 10:30Pressemelding

Nexodyn® AcidOxidizing Solution (AOS), the Tehclo-based product for acute and chronic wound management, is now available in Slovakia, promoted and commercialized by the pharmaceutical companies Evopharm and Sanomed, pursuant to an exclusive partnership with the Swiss pharma company APR Applied Pharma Research s.a. (“APR”). After Slovakia, in early 2019 Evopharm will expand the distribution of the product first to Poland, where the registration is currently being completed, and then to Czech Republic. As confirmed by the results of pre-launch activities, Evopharm is confident that Nexodyn® AOS, based on APR’s proprietary and patented technology Tehclo®, can offer to Slovak Healthcare Professionals (“HCPs”) and caregivers a new treatment option to effectively address the wound healing complexity. Local KOLs, involved in an Advisory Board, got particularly impressed from the distinctive physico-chemical properties of this product, able to create the ideal microenvironment to sustain the p

Kao Data Invests in euNetworks High Density Fibre as Part of a North London Artery11.12.2018 09:07Pressemelding

Kao Data, the home of innovation and UK’s leading entrant to the wholesale colocation market, has announced it is working with euNetworks, a Western European bandwidth infrastructure provider. This enables the delivery of high-density fibre and duct to the Kao Data, Harlow based data centre campus north of London. The new infrastructure provides unique routing opportunities, taking advantage of Harlow’s strategic location between core hyperscale campuses in Dublin and Amsterdam. It also offers fast connection to Slough, to the West of London, and Docklands in the East of London. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181211005308/en/ Kao Data Invests in euNetworks High Density Fibre as Part of a North London Artery (Photo: Business Wire) As the UK continues its strong position in the international data centre market, a series of significant investments in high-density fibre routes are underway to support hyperscale d

Spirent Helps High-Speed Setup For Aston Martin Racing11.12.2018 08:00Pressemelding

Spirent Communications plc (LSE:SPT), the world leader in test, measurement, assurance, and analytics solutions for next-generation devices and networks, today announced that Aston Martin Racing (AMR) is using its Test as a Service (TaaS) platform, iTest, to assist the iconic automotive brand’s bid for FIA World Endurance Championship GTE category success. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181211005239/en/ Spirent's technical partnership with Aston Martin Racing has dramatically reduced the team's high-speed LAN test and set-up time at FIAWEC events. (Photo: Business Wire) Aston Martin Racing deploys a high-speed local area network (LAN) trackside to connect team drivers and cars with the pit crew, engineers and managers on pit lane, to carry radio communications, telemetry and video data. The FIAWEC Super Season includes some of the world’s most grueling tests of driver and car – including the famous Le Mans 24

WaveOptics Raises $26m to Scale Business and Support International Expansion in Its First Stage of Series C Funding11.12.2018 08:00Pressemelding

WaveOptics, the world leading designer and manufacturer of diffractive waveguides for use in Augmented Reality (AR) wearables, has raised $26 million (£20m) from existing shareholders and new investors. The capital raised will be used to scale up the business operations on a national and international basis. This round was led by Octopus Ventures, one of WaveOptics’ largest shareholders and one of Europe’s most prominent venture capital firms. The fundraise was supported by other existing shareholders including IP Group, Robert Bosch Venture Capital and Gobi Partners, as well as new investors Goertek and Optimas Capital Partners. David Hayes, WaveOptics CEO, commented: “We have made excellent progress over the last year with our high performing, manufacturable, and versatile waveguides. We are now working with a wide range of leading global OEMs and ODMs as they ramp up the development of their products. “These additional funds will enable us to scale up rapidly around the world, parti

Yamaha Motor Outline of Long-term Vision & New Medium-term Management Plan11.12.2018 06:05Pressemelding

Yamaha Motor Co., Ltd. (TOKYO:7272) announced today that it has formulated its long-term vision until 2030, and a New Medium-term Management Plan for the three-year period starting in 2019. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181210005244/en/ (Photo: Business Wire) For its long-term vision, Yamaha Motor has created the slogan “ART for Human Possibilities” and devised a growth strategy heading for 2030. For increasingly diversifying people's values and the environment around societies, the Company will implement its growth strategies while promoting solutions to social issues based on its own historical values. While maintaining the earning power from existing businesses, the new medium-term management plan will allocate resources to strategic growth areas such as new business, and work toward achieving consolidated net sales of 2-trillion yen and a consolidated operating income of 180 billion yen. View source vers